PET RX's
F-18 T1/2- 110 min
FDG
Diffusion
o PET imaging for abnormal glucose metabolism in malignant tissues
o PET imaging for coronary artery disease
o PET imaging for abnormal glucose uptake in seizure activity.
Florbetaben
Receptor Binding
o PET imaging to estimate b-amyloid neuritic plaque density in patients with suspected Alzheimer’s
Florbetapir
Receptor Binding
o PET imaging to estimate b-amyloid neuritic plaque density in patients with suspected Alzheimer’s
Flutemetamol
Receptor Binding
o PET imaging to estimate b-amyloid neuritic plaque density in patients with suspected Alzheimer’s
Sodium Flouride
Chemisorption
o PET imaging of bone to define areas of altered osteogenic activity
Fluciclovine
Receptor Binding
o PET imaging in men with suspected prostate cancer
Rb-82 T1/2 - 75 sec
Active Transport
o PET Myocardial perfusion imaging under rest and pharmacologic stress conditions to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease
N-13 T1/2 - 10 min
Active Transport
o PET Myocardial perfusion imaging under rest and pharmacologic stress conditions to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease
Ga-68 T1/2 - 68 min
Receptor Binding
o PET imaging for localization of somatostatin receptor positive neuroendocrine tumors